Most people who stop using GLP-1s regain the weight they lost, even with sustained lifestyle changes
*Please Note, If your GLP medication is denied coverage we do not offer appeals
[3] [14] The FDA has approved several GLP-1 receptor agonists for clinical use, each with distinct characteristics regarding formulation, dosing frequency, and approved indications
273 In addition, in a rat model of inflammatory OA induced by monoiodoacetic acid (MIA), researchers have shown that the activation of GLP-1R triggers the PKA/CREB signaling pathway, leading to a reduction in cartilage inflammation
Disclosures: Prabhu Ponnandy: Nothing to Disclose, Chinmay Raut: Nothing to Disclose, Rawdat Hussain: Nothing to Disclose, Akram Irshaid: Nothing to Disclose, Brian Halligan: Nothing to Disclose, Elizabeth Speliotes: Nothing to Disclose 2559 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE ASSOCIATED ALLELE GCKR (P446L) PROMOTES FGF21 SECRETION VIA UP-REGULATING TRANSCRIPTION FACTOR CHREBP IN HUH-7 CELL LINE Yue Chen 1 Rawdat Hussain 1 Jason Chen 2 Antonio Oliveri 1 Brian Halligan 1 Elizabeth Speliotes 1 , 1 University of Michigan Medical Center, 2 Judd A